External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data by Eleni Karatza, Samit Ganguly, Samit Ganguly, Chi D. Hornik, William J. Muller, Amira Al-Uzri, Laura James, Stephen J. Balevic, Daniel Gonzalez

Connect to this object online.

An anthropometric survey of US pre-term and full-term neonates by Susan M. Abdel-Rahman, Ian M. Paul, Paula Delmore, Laura James, Laura Fearn, Andrew M. Atz, Brenda B. Poindexter, Amira Al-Uzri, Andrew Lewandowski, Barrie L. Harper, P. Brian Smith, for the Best Pharmaceuticals for Children Act - Pediatric Trials Network

Connect to this object online.

A Weight Estimation Strategy for Preterm and Full-Term Infants by Susan M. Abdel-Rahman PharmD, Ian M. Paul MD, Paula Delmore RN, Laura James MD, Laura Fearn RN, Andrew Atz MD, Brenda Poindexter MD, Amira Al-Uzri MD, Andrew Lewandowski PhD, Barrie Harper, P. Brian Smith MD

Connect to this object online.

Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity by Jacqueline G. Gerhart, Fernando O. Carreño, Jennifer L. Ford, Andrea N. Edginton, Eliana M. Perrin, Kevin M. Watt, William J. Muller, Andrew M. Atz, Amira Al‐Uzri, Paula Delmore, Daniel Gonzalez, Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee

Connect to this object online.